Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Go

Showing results (491-500 of 1,168) with videos related to

Pageof 117
Sort By:
Journal of Hypertension|January 11, 2013
Sex differences in cardiovascular outcomes in patients with incident hypertensionStacie L Daugherty, Frederick A Masoudi, Chan Zeng, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 23, 2026
Atrial Fibrillation and Stroke Prevention and Management in Chronic Kidney DiseaseNisha Bansal, David M Charytan, Amit X Garg, et al.
The American Journal of Managed Care|September 10, 2011
Mental illness and warfarin use in atrial fibrillationGraham A Walker, Paul A Heidenreich, Ciaran S Phibbs, et al.
Journal of the American Heart Association|April 13, 2017
Health Literacy and Awareness of Atrial FibrillationStephanie R Reading, Alan S Go, Margaret C Fang, et al.
Journal of the American College of Cardiology|April 8, 2014
Comparative effectiveness of clopidogrel in medically managed patients with unstable angina and non-ST-segment elevation myocardial infarctionMatthew D Solomon, Alan S Go, David Shilane, et al.
The American Journal of Cardiology|February 6, 2013
Comparison of medication practices in patients with heart failure and preserved versus those with reduced ejection fraction (from the Cardiovascular Research Network [CVRN])Robert J Goldberg, Jerry H Gurwitz, Jane S Saczynski, et al.
Journal of Thrombosis and Thrombolysis|October 24, 2003
Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyAlan S Go, Guy L Reed, Elaine M Hylek, et al.
Circulation|July 6, 2000
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) studyA S Go, E M Hylek, K A Phillips, et al.
American Heart Journal|November 24, 2007
Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?Haruka Itakura, Burton E Sobel, Derek Boothroyd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2013
ECOG phase II trial of graded-dose peginterferon α-2b in patients with metastatic melanoma overexpressing basic fibroblast growth factor (E2602)Ronald S Go, Sandra J Lee, Donghoon Shin, et al.
Pageof 117

Showing results (491-500 of 1,168) with videos related to

Sort By:
Pageof 117
Journal of Hypertension|January 11, 2013
Sex differences in cardiovascular outcomes in patients with incident hypertensionStacie L Daugherty, Frederick A Masoudi, Chan Zeng, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 23, 2026
Atrial Fibrillation and Stroke Prevention and Management in Chronic Kidney DiseaseNisha Bansal, David M Charytan, Amit X Garg, et al.
The American Journal of Managed Care|September 10, 2011
Mental illness and warfarin use in atrial fibrillationGraham A Walker, Paul A Heidenreich, Ciaran S Phibbs, et al.
Journal of the American Heart Association|April 13, 2017
Health Literacy and Awareness of Atrial FibrillationStephanie R Reading, Alan S Go, Margaret C Fang, et al.
Journal of the American College of Cardiology|April 8, 2014
Comparative effectiveness of clopidogrel in medically managed patients with unstable angina and non-ST-segment elevation myocardial infarctionMatthew D Solomon, Alan S Go, David Shilane, et al.
The American Journal of Cardiology|February 6, 2013
Comparison of medication practices in patients with heart failure and preserved versus those with reduced ejection fraction (from the Cardiovascular Research Network [CVRN])Robert J Goldberg, Jerry H Gurwitz, Jane S Saczynski, et al.
Journal of Thrombosis and Thrombolysis|October 24, 2003
Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyAlan S Go, Guy L Reed, Elaine M Hylek, et al.
Circulation|July 6, 2000
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) studyA S Go, E M Hylek, K A Phillips, et al.
American Heart Journal|November 24, 2007
Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?Haruka Itakura, Burton E Sobel, Derek Boothroyd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2013
ECOG phase II trial of graded-dose peginterferon α-2b in patients with metastatic melanoma overexpressing basic fibroblast growth factor (E2602)Ronald S Go, Sandra J Lee, Donghoon Shin, et al.
Pageof 117